
    
      The primary objective of this study is to establish the safety and efficacy of the
      combination of Entecavir and Fuzheng Huayu for reverse rate of gastroesophageal varices in
      patients with low-grade cirrhotic portal hypertension due to hepatitis B virus.
    
  